Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Global Contrast Injector Systems Market to reach a market size of $1.03 billion by 2024

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Contrast Injector Systems Market, published by KBV research, The Global Contrast Injector Systems Market size is expected to reach $1.03 billion by 2024, rising at a market growth of 7.9% CAGR during the forecast period.

The North America market would dominate the Global Radiology Market by Region by 2024; growing at a CAGR of 6.3 % during the forecast period. The Europe market is expected to witness a CAGR of 6.7% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.3% during (2018 - 2024).

The Consumables market dominated the Global Contrast Injector Systems Market by Product in 2017, growing at a CAGR of 7.5 % during the forecast period. The Injector Systems market is expected to witness a CAGR of 8.2% during (2018 - 2024).

The Hospitals market dominated the Global Contrast Injector Systems Market by End User in 2017. The Diagnostics Centers market is expected to witness a CAGR of 7.1% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/contrast-injector-systems-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bayer Ag, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.

Global Contrast Injector Systems Market Segmentation

By Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By Product

  • Injector
  • CT Injector Systems
  • MRI Injector Systems
  • Angiography Injector Systems
  • Consumables
  • Syringes
  • Injector Head
  • Tubing
  • Others
  • Accessories

By End User

  • Hospitals
  • Diagnostics
  • Other

 By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bayer Ag
  • Angiodynamics Inc.
  • GE Healthcare (A Healthcare Division of GE Company)
  • Medtron AG
  • Nemoto Kyorindo Co., Ltd.
  • Sino Medical- Device Technology Co., Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd.
  • Ulrich GmbH & Co. Kg
  • Vivid Imaging
  • Guerbet Group

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Contrast Injector Systems Market (2018-2024)

Europe Contrast Injector Systems Market (2018-2024)

Asia Pacific Contrast Injector Systems Market (2018-2024)

LAMEA Contrast Injector Systems Market (2018-2024)



SUBSCRIPTION MODEL